Your browser doesn't support javascript.
loading
Identification of protein phosphatase involvement in the AT2 receptor-induced activation of endothelial nitric oxide synthase.
Peluso, A Augusto; Bertelsen, Jesper Bork; Andersen, Kenneth; Mortsensen, Tenna Pavia; Hansen, Pernille B; Sumners, Colin; Bader, Michael; Santos, Robson A; Steckelings, Ulrike Muscha.
Afiliação
  • Peluso AA; IMM - Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
  • Bertelsen JB; IMM - Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
  • Andersen K; IMM - Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
  • Mortsensen TP; IMM - Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
  • Hansen PB; IMM - Department of Cardiovascular and Renal Research, University of Southern Denmark, Odense, Denmark.
  • Sumners C; Cardiovascular and Metabolic Disease, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden.
  • Bader M; Department of Physiology and Functional Genomics, University of Florida, Gainesville, FL, U.S.A.
  • Santos RA; Max Delbrück Center for Molecular Medicine, Berlin, Germany.
  • Steckelings UM; National Institute of Science and Technology in Nanobiopharmaceutics, Department of Physiology and Biophysics, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
Clin Sci (Lond) ; 132(7): 777-790, 2018 04 16.
Article em En | MEDLINE | ID: mdl-29540539
ABSTRACT
The Angiotensin II type 2 receptor (AT2R) promotes vasodilation by nitric oxide (NO) release from endothelial cells. However, the mechanisms underlying the AT2R-induced stimulation of endothelial NO synthase (eNOS) is still not completely understood. Therefore, we investigated whether in addition to the known AT2R-mediated phosphorylation of eNOS at Ser1177, activation of phosphatases and dephosphorylation of eNOS at Tyr657 and Thr495 are also involved. Human aortic endothelial cells (HAEC) were stimulated with the AT2R-agonist Compound 21 (C21) (1 µM) in the presence or absence of either PD123319 (10 µM; AT2R antagonist), l-NG-Nitroarginine methyl ester (l-NAME) (10 µM; eNOS inhibitor), MK-2206 (100 nM; protein kinase B (Akt) inhibitor) sodium fluoride (NaF) (1 nM; serine/threonine phosphatase inhibitor) or sodium orthovanadate (Na3VO4) (10 nM; tyrosine phosphatase inhibitor). NO release was estimated by quantifying 4-amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM) fluorescence. The phosphorylation status of activating (eNOS-Ser1177) or inhibitory eNOS residues (eNOS-Tyr657, eNOS-Thr495) was determined by Western blotting. Phosphorylation of Akt at Ser473 was measured to estimate Akt activity. AT2R stimulation significantly increased NO release from HAEC, which was blocked by PD123319, l-NAME and both phosphatase inhibitors. Intracellular calcium transients were not changed by C21. AT2R stimulation resulted in phosphorylation of eNOS-Ser1177 and dephosphorylation of eNOS-Tyr657 and eNOS-Thr495 Phosphorylation at eNOS-Ser1177 was prevented by inhibition of Akt with MK-2206. From these data, we conclude that AT2R stimulation in human endothelial cells increases eNOS activity through phosphorylation of activating eNOS residues (eNOS-Ser1177) by Akt, and through dephosphorylation of inactivating eNOS residues (eNOS-Tyr657, eNOS-Thr495) by serine/threonine and tyrosine phosphatases, thus increasing NO release.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptor Tipo 2 de Angiotensina / Óxido Nítrico Sintase Tipo III Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Clin Sci (Lond) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Receptor Tipo 2 de Angiotensina / Óxido Nítrico Sintase Tipo III Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Clin Sci (Lond) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Dinamarca